Sunshine Biopharma Inc (SBFM)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
Market Cap: $2.22M
Last updated: Nov 17, 2026 at 11:05 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 73.0% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 28.2, below 30, the oversold line.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about SBFM
News
SBFM Valuation
- P/FCF
- -0.1x
- P/B
- 0.0x
SBFM Profitability: Margins, ROIC and FCF
Sunshine Biopharma (SBFM) has a gross margin of 30.4%, an operating margin of -16.8% and a net margin of -17.4%. It posts a -15.1% FCF margin.
- Gross margin
- 30.4%
- Operating margin
- -16.8%
- Net margin
- -17.4%
- ROE
- -23.4%
- FCF margin
- -15.1%
- FCF yield
- -875.3%
Sunshine Biopharma Competitors
The companies most similar to Sunshine Biopharma (SBFM) include Redhill Biopharma, PRF Technologies and cbdMD.
Sector: Healthcare
Companies most similar to Sunshine BiopharmaSBFM Bull Case vs Bear Case
Bear case
- SBFM has a -17.4% net profit margin.
- SBFM beat EPS estimates in 25.0% of its last 8 reported quarters.
SBFM Earnings: Beat Rate and Next Report
Sunshine Biopharma (SBFM) beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate (25.0%). Its next report is expected on Apr 1, 2027.
- Beat rate
- 2 of 8 quarters (25.0%)
- Average surprise
- -164.7%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$5.92
SBFM Earnings Date
SBFM reports Apr 1, 2027. The date is estimated.
Updated Nov 12, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About SBFM
When does SBFM report earnings?
Sunshine Biopharma Inc (SBFM) is expected to report earnings on Apr 1, 2027.
Does SBFM pay dividends?
Sunshine Biopharma Inc (SBFM) does not currently pay a regular dividend.
What is SBFM's market cap?
Sunshine Biopharma Inc (SBFM) has a market capitalization of $2.22M with a current stock price of $2.60.
SBFM pages: Overview, Earnings, Forecast, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.